StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a report released on Wednesday morning. The firm issued a buy rating on the stock.
Mannatech Price Performance
MTEX stock opened at $7.98 on Wednesday. The company has a quick ratio of 0.56, a current ratio of 1.08 and a debt-to-equity ratio of 0.09. Mannatech has a 12 month low of $7.30 and a 12 month high of $15.10. The firm has a market cap of $15.00 million, a P/E ratio of -8.97 and a beta of 1.17. The company’s 50-day moving average price is $7.90 and its two-hundred day moving average price is $8.41.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its quarterly earnings results on Tuesday, May 14th. The company reported $0.63 earnings per share (EPS) for the quarter. The company had revenue of $29.39 million for the quarter. Mannatech had a negative net margin of 1.31% and a negative return on equity of 15.37%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Articles
- Five stocks we like better than Mannatech
- Which Wall Street Analysts are the Most Accurate?
- Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
- What Does a Stock Split Mean?
- Campbell Soup Co. Targets Fiscal Q4 Stock Recovery
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Zebra Analysts Upgrade Stock, Forecasting Major Reversal
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
